SCHEMBL5848271

SCHEMBL5848271

Cc1nc(Cl)c(Cl)n1CCCCN1CCC(O)(c2ccccc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.53
CCR3 P51677 1/20 0.53
DRD2 P14416 5/20 0.49
HTR1A P08908 2/20 0.49
DRD4 P21917 2/20 0.49
HTR2A P28223 2/20 0.49
DRD3 P35462 2/20 0.49
CCR1 P32246 1/20 0.48
OPRL1 P41146 2/20 0.48
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.47
POLB P06746 1/20 0.47
SLC6A4 P31645 1/20 0.47
HTR7 P34969 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159869 0.91 CCR1 (0.50) CCR3DRD2HTR1ADRD4HTR2A
SCHEMBL5846508 0.91 CCR3 (0.56) CCR3DRD2HTR1ADRD4HTR2A
SCHEMBL5847174 0.89 DRD2 (0.57) SIGMAR1DRD2HTR1ADRD4HTR2A
SCHEMBL5846506 0.86 DRD2 (0.50) SIGMAR1CCR3DRD2HTR1ADRD4
SCHEMBL5848902 0.85 OPRL1 (0.54) SIGMAR1DRD2HTR1ADRD4HTR2A
SCHEMBL8416503 0.78 HTR1A (0.61) SIGMAR1DRD2HTR1AHTR2ADRD3
SCHEMBL8416472 0.76 KDM4E (0.61) DRD2HTR1ADRD4HTR2ADRD3
SCHEMBL11778752 0.74 SIGMAR1 (0.70) SIGMAR1CCR3DRD2CCR1OPRL1
SCHEMBL11062805 0.74 SIGMAR1 (0.70) SIGMAR1CCR3DRD2CCR1OPRL1
SCHEMBL8416539 0.73 HTR2A (0.55) SIGMAR1DRD2HTR1AHTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39113-E1 Utilization of derivatives of tetrahydropyridines(or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2006-05-30 US claimed
EP-0721455-B9 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2005-04-20 EP claimed
EP-1097698-B1 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN ESTEVE LABOR DR (ES) 2003-05-07 EP claimed
EP-0721455-B1 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2002-12-11 EP claimed
EP-1097698-A2 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2001-05-09 EP claimed
WO-1996004287-A1 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1996-02-15 WO claimed